Effects of Acupuncture Treatment on Blood LPO and SOD Contents in Parkinsonism Patients
|更新时间:2023-08-11
|
Effects of Acupuncture Treatment on Blood LPO and SOD Contents in Parkinsonism Patients
Acupuncture ResearchIssue 1, Pages: 28-31(2001)
作者机构:
中国中医研究院针灸研究所,北京,100700
作者简介:
基金信息:
DOI:
CLC:
Published:2001
稿件说明:
移动端阅览
Effects of Acupuncture Treatment on Blood LPO and SOD Contents in Parkinsonism Patients[J]. Acupuncture research, 2001, (1): 28-31.
DOI:
Effects of Acupuncture Treatment on Blood LPO and SOD Contents in Parkinsonism Patients[J]. Acupuncture research, 2001, (1): 28-31.DOI:
Effects of Acupuncture Treatment on Blood LPO and SOD Contents in Parkinsonism Patients
摘要
本文观察了针刺治疗震颤麻痹对患者血中LPO和SOD含量的影响
结果表明
针刺能提高震颤麻痹病人血中超氧化物歧化酶 (SOD)的含量
而其中以病程短的病人血中SOD含量升高较为显著
同时发现
年龄在 60岁以上者及女性病人针刺后血中SOD增长幅度较大。
Abstract
Objective: To observe effects of acupuncture treatment on blood LPO and SOD contents in Parkinsonism patients. Methods: 87 Parkinsonism patients were randomly divided into acupuncture group (n= 59) and medication group (n= 28). Acupoints as Xiaochan point (1.5 cun inferior to Shaohai HT 3)
Waiguan (TE 5)
Hegu (LI 4)
Yanglingquan (GB 34)
Taichong (LR 3)
Zusanli (ST 36)
etc were used and stimulated with uniform reinforcing reducing needling method. The treatment was given once daily
with 10 sessions being a therapeutic course
continuously for 3 courses. Patients in medication group were treated with madopar
sinemet
artane
etc based on the doctor's requirements. Plasma LPO content and SOD content of red blood cells were detected by using thiobarbituric acid via lipid peroxide malonyldialdehyde technique and radioimmunoassay respectively.Results: Results showed that after acupuncture treatment
SOD content increased significantly
particularly in patients above 60 years at age
female patients and the patients with disease duration being less than 3 years in comparison with those under 60 years
male patients and those with disease duration being over 3 years respectively. Conclusion: Acupuncture can function well in preventing Parkinsonism from exacerbation particularly in patients above 60 years old
female patients and those with shorter duration of disease.